endogenousCapacity
Describes the body's internal ability to produce a required substance or maintain a physiological function. Explains whether and to what extent the body can meet a requirement without external sources.
Why This Property Exists
Understanding why external intervention is necessary requires knowing what the body can and cannot do for itself. Many health recommendations only make sense in context of the body's internal production capacity:
- Lips need external lipids because the vermilion border has zero sebaceous glands
- Vitamin C supplementation matters because humans lost the ability to synthesise it
- Collagen peptide supplements are debated because the body can synthesise collagen from amino acids
Without this context, recommendations appear arbitrary. With it, the rationale becomes clear.
Schema.org can describe what a tissue needs (physiologicalBenefits) or what a substance does, but cannot express the gap between what the body produces and what it requires. The endogenousCapacity property fills this gap by explicitly stating the body's internal production capability—or lack thereof.
This enables:
- Justified recommendations: Explain why external sources are necessary, not just what to use
- Comparative analysis: Distinguish between tissues that need support (lips) and those that self-maintain (most facial skin)
- Nuanced guidance: Capture partial capacity (body makes some but not enough) versus zero capacity
- Educational content: Help readers understand the physiological basis for interventions
Domain and Range
Used On (Domain)
| Type | Context |
|---|---|
| hs:PhysiologicalRequirement | Describes the body's ability to meet the specified requirement internally |
Expected Values (Range)
| Type | Notes |
|---|---|
| schema:Text | Free text description of the body's internal production capacity. Should clearly indicate whether capacity is zero, partial, or sufficient, and explain why. |
Distinction From Related Properties
Several properties in PhysiologicalRequirement work together to tell a complete story:
| Property | Answers | Example |
|---|---|---|
| requirement | "What does this tissue need?" | "Protective lipid barrier" |
| endogenousCapacity | "Can the body provide it?" | "Zero production capacity; no sebaceous glands present" |
| externalSources | "Where else can it come from?" | Tallow, lanolin, shea butter, jojoba oil |
| consequenceIfUnmet | "What happens without it?" | "Chronic dryness, cracking, discomfort" |
Together, these properties create a logical chain: the tissue has a requirement → the body can/cannot meet it → external sources exist → consequences if unmet. endogenousCapacity is the critical link explaining why external sources matter.
Usage Guidance
Do
- Be specific about capacity level—"zero", "partial", "sufficient under normal conditions", "declines with age"
- Explain the biological basis—why can't the body produce this? Missing glands? Lost gene? Insufficient precursors?
- Include comparative context when helpful—"unlike facial skin which has thousands of sebaceous glands per square centimetre"
- Note conditions that affect capacity—age, disease states, nutritional status
Don't
- Simply state "none" or "yes"—explain the mechanism
- Confuse production with storage—the body might store but not produce, or produce but not store
- Ignore context-dependency—capacity may vary by age, health status, or environmental conditions
Capacity Spectrum
Endogenous capacity exists on a spectrum. Here's how to characterise different points:
| Capacity Level | Characteristics | Example |
|---|---|---|
| Zero | Body completely lacks the ability; external source essential | Lip sebum production (no glands), human vitamin C synthesis (lost gene) |
| Insufficient | Body produces some but not enough for optimal function | Collagen production in elderly, melatonin in shift workers |
| Conditional | Sufficient under normal conditions, insufficient under stress/disease/age | Glutamine (conditionally essential amino acid) |
| Sufficient | Body meets requirements internally; external sources optional | Cholesterol synthesis, most non-essential amino acids |
Examples
Example 1: Zero Capacity
Lip tissue lipid requirement:
{
"@type": "PhysiologicalRequirement",
"@id": "#PhysiologicalRequirement/LipLipidRequirement",
"name": "Lip tissue lipid requirement",
"tissue": {"@id": "#AnatomicalStructure/VermilionBorder"},
"requirement": "Protective lipid barrier (sebum-like oils)",
"endogenousCapacity": "Zero production capacity; the vermilion border contains no sebaceous glands whatsoever, unlike facial skin which has thousands per square centimetre",
"externalSources": [
{"@id": "#ChemicalSubstance/BeefTallow"},
{"@id": "#ChemicalSubstance/Lanolin"},
{"@id": "#ChemicalSubstance/SheaButter"}
],
"consequenceIfUnmet": {
"@type": "MedicalCondition",
"name": "Chronic lip dryness and vulnerability"
}
}
Why this works: The description is explicit ("zero production capacity"), explains the anatomical reason (no sebaceous glands), and provides comparative context (unlike facial skin).
Example 2: Age-Dependent Decline
Collagen production in ageing skin:
{
"@type": "PhysiologicalRequirement",
"name": "Dermal collagen maintenance",
"tissue": {"@id": "#AnatomicalStructure/Dermis"},
"requirement": "Continuous collagen synthesis to replace degraded fibres",
"endogenousCapacity": "Fibroblasts produce collagen throughout life, but production declines 1-2% annually after age 20. By age 40, production may be insufficient to maintain dermal thickness without support. Oestrogen decline during perimenopause accelerates this loss.",
"externalSources": [
{
"@type": "MedicalTherapy",
"name": "Topical retinoids",
"description": "Stimulate fibroblast collagen production"
},
{
"@type": "TherapeuticProcedure",
"name": "PRP therapy",
"description": "Growth factors stimulate collagen synthesis"
}
],
"consequenceIfUnmet": {
"@type": "MedicalCondition",
"name": "Skin thinning and wrinkle formation"
}
}
Why this works: Capacity isn't binary—it changes with age. The description captures this nuance with specific percentages and identifies a trigger (perimenopause) that accelerates decline.
Example 3: Conditional Capacity
Glutamine in critical illness:
{
"@type": "PhysiologicalRequirement",
"name": "Glutamine availability",
"tissue": {
"@type": "AnatomicalStructure",
"name": "Skeletal muscle and immune cells"
},
"requirement": "Adequate glutamine for protein synthesis and immune function",
"endogenousCapacity": "Sufficient under normal conditions—skeletal muscle synthesises and releases glutamine. However, during critical illness, trauma, or severe infection, demand exceeds production capacity by 2-3 fold, making glutamine conditionally essential.",
"externalSources": [
{
"@type": "DietarySupplement",
"name": "Glutamine supplementation",
"description": "20-30g daily in divided doses during recovery"
}
],
"consequenceIfUnmet": {
"@type": "MedicalCondition",
"name": "Impaired immune function and delayed wound healing"
}
}
Why this works: The description captures conditionality—normally sufficient, but insufficient under specific circumstances. This explains why supplementation is sometimes recommended and sometimes unnecessary.
Example 4: Species-Level Inability
Human vitamin C synthesis:
{
"@type": "PhysiologicalRequirement",
"name": "Vitamin C availability",
"tissue": {
"@type": "AnatomicalStructure",
"name": "All tissues (systemic requirement)"
},
"requirement": "Ascorbic acid for collagen synthesis, antioxidant function, and enzyme cofactor roles",
"endogenousCapacity": "Zero. Humans lost functional L-gulonolactone oxidase (GULO gene) approximately 61 million years ago. Unlike most mammals, we cannot synthesise vitamin C from glucose and are entirely dependent on dietary intake.",
"externalSources": [
{
"@type": "Food",
"name": "Citrus fruits, berries, peppers, leafy greens"
},
{
"@type": "DietarySupplement",
"name": "Ascorbic acid supplements"
}
],
"consequenceIfUnmet": {
"@type": "MedicalCondition",
"name": "Scurvy",
"description": "Collagen synthesis failure leading to bleeding gums, wound dehiscence, and death if untreated"
}
}
Why this works: Explains the evolutionary/genetic basis for zero capacity, making it clear this is a species-level limitation, not individual variation.
Implementation Notes
Relationship to externalSources
endogenousCapacity and externalSources are logically connected but serve different purposes:
endogenousCapacityexplains why external sources matterexternalSourceslists what those sources are
A PhysiologicalRequirement with sufficient endogenous capacity might have empty or optional externalSources. Conversely, zero endogenous capacity makes externalSources essential.
Validation
Standard schema.org validators will not recognise this property. This is expected for Health Schema extensions. The property is defined in the Health Schema context and will be correctly interpreted by systems that load this context.